Preclinical Efficacy of Pro- and Anti-Angiogenic Peptide Hydrogels to Treat Age-Related Macular Degeneration
Pro-angiogenic and anti-angiogenic peptide hydrogels were evaluated against the standard of care wet age-related macular degeneration (AMD) therapy, Aflibercept (Eylea<sup>®</sup>). AMD was modeled in rats (laser-induced choroidal neovascularization (CNV) model), where the contralateral...
| Váldodahkkit: | , , , , , , , |
|---|---|
| Materiálatiipa: | Artihkal |
| Giella: | English |
| Almmustuhtton: |
MDPI AG
2021-11-01
|
| Ráidu: | Bioengineering |
| Fáttát: | |
| Liŋkkat: | https://www.mdpi.com/2306-5354/8/12/190 |